Industry News
Biotechnology Industry News

GSK, Korean biotech SK go head-to-head against AstraZeneca’s COVID-19 shot with their experimental vaccine
GSK, Korean biotech SK go head-to-head against AstraZeneca's COVID-19 shot with their experimental vaccine badams Tue, 08/31/2021 - 08:08
A year after a death and accompanying trial hold, Poseida hopes for reprieve with early solid tumor CAR-T data
A year after a death and accompanying trial hold, Poseida hopes for reprieve with early solid tumor CAR-T data badams Tue, 08/31/2021 - 05:39
The descent of van de Stolpe: Galapagos CEO exits after R&D setbacks wipe out billions in value
The descent of van de Stolpe: Galapagos CEO exits after R&D setbacks wipe out billions in value ntaylor Tue, 08/31/2021 - 04:37
Brain cancer biotech Ziopharm snaps up new CEO from Kuur Therapeutics
Brain cancer biotech Ziopharm snaps up new CEO from Kuur Therapeutics klahucik Mon, 08/30/2021 - 09:48
Ziopharm snaps up new CEO from Kuur Therapeutics
Ziopharm snaps up new CEO from Kuur Therapeutics klahucik Mon, 08/30/2021 - 09:48
Pfizer’s abrocitinib beats blockbuster Dupixent in phase 3 eczema trial, but key questions remain
Pfizer's abrocitinib beats blockbuster Dupixent in phase 3 eczema trial, but key questions remain ntaylor Mon, 08/30/2021 - 08:44
SPAC backs Revelation to tackle respiratory viral infections
SPAC backs Revelation to tackle respiratory viral infections ntaylor Mon, 08/30/2021 - 08:02
Thwarting a cancer-promoting enzyme with a 2-pronged strategy to induce cell death
Thwarting a cancer-promoting enzyme with a 2-pronged strategy to induce cell death arlene.weintraub Fri, 08/27/2021 - 10:59
BeyondSpring, flying high from phase 3 success, sells Chinese rights to cancer drug
BeyondSpring, flying high from phase 3 success, sells Chinese rights to cancer drug ntaylor Fri, 08/27/2021 - 08:11
Agenus, with FDA approval in sight, showcases anti-PD-1 data
Agenus, with FDA approval in sight, showcases anti-PD-1 data ntaylor Fri, 08/27/2021 - 05:40
AstraZeneca’s $39B Alexion buyout bears fruit, yielding late-phase win for potential blockbuster rare disease drug
AstraZeneca's $39B Alexion buyout bears fruit, yielding late-phase win for potential blockbuster rare disease drug ntaylor Thu, 08/26/2021 - 07:37
Sesen, still reeling from FDA rejection, pulls filing for EU approval of cancer drug
Sesen, still reeling from FDA rejection, pulls filing for EU approval of cancer drug ntaylor Thu, 08/26/2021 - 06:06
Replimune axes CMO role and CMO Pirzkall along with it
Replimune axes CMO role and CMO Pirzkall along with it badams Thu, 08/26/2021 - 04:12
Unraveling the link between migraines and protection against diabetes
Unraveling the link between migraines and protection against diabetes klahucik Wed, 08/25/2021 - 11:46
Bristol-backed Cardior gets $75M to run midphase antisense heart failure trial
Bristol-backed Cardior gets $75M to run midphase antisense heart failure trial ntaylor Wed, 08/25/2021 - 08:05
Improving CAR-T cell therapy with more sensitive tumor identification
Improving CAR-T cell therapy with more sensitive tumor identification aliu Wed, 08/25/2021 - 06:14
Brii’s COVID-19 antibody slashes hospitalizations and deaths in late-phase trial, teeing it up to take on Regeneron
Brii's COVID-19 antibody slashes hospitalizations and deaths in late-phase trial, teeing it up to take on Regeneron ntaylor Wed, 08/25/2021 - 05:55
Atavistik Bio secures $60M series A to tackle metabolic diseases, cancers with former Peloton, Blueprint Medicines execs at the helm
Atavistik Bio secures $60M series A to tackle metabolic diseases, cancers with former Peloton, Blueprint Medicines execs at the helm klahucik Tue, 08/24/2021 - 17:24
Pfizer deal a spark for M&A, or just fuel for an empty pipeline? Analysts try to read the tea leaves
Pfizer deal a spark for M&A, or just fuel for an empty pipeline? Analysts try to read the tea leaves badams Tue, 08/24/2021 - 09:33
The link between COVID-19, rattlesnake venom and a killer enzyme inspires treatment target
The link between COVID-19, rattlesnake venom and a killer enzyme inspires treatment target arlene.weintraub Tue, 08/24/2021 - 09:03

